Oppenheimer Upgrades Arvinas Inc. (ARVN) to Outperform, Following Clinical Update
Tweet Send to a Friend
Oppenheimer analyst Mark Breidenbach upgraded Arvinas Inc. (NASDAQ: ARVN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
